Drug Trial Radar · NCT02269241
Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
Last checked: Nov 19, 2026Latest source record: Aug 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,552
Actual
Start
Oct 9, 2014
Primary completion
Oct 4, 2017
Study completion Oct 4, 2017
Sponsor
- Lead sponsor
- Laboratories Leon Farma, S.A.Industry
- Sponsor type
- Industry
- Collaborators
- Chemo France
- First posted
- Oct 21, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 15 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To demonstrate the contraceptive efficacy of LF111 . To demonstrate the safety and tolerability of LF111 and assessment of pharmacokinetics of LF111.
Conditions
- Contraception
Interventions
LF111 (drospirenone)Drug
One LF111 tablet once per day for 24 days followed by 4 placebo tablets for 4 days equals one cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Pregnancies (Evaluable Cycles)Time frame: up to 13 months
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics
Birmingham, Alabama
Anaheim Clinical Trials, LLC
Anaheim, California
WCCT Global
Costa Mesa, California
Women's Health Care Research Corp.
San Diego, California
Downtown Women's Health Care
Denver, Colorado
Horizons Clinical Research Center, LLC
Denver, Colorado
Stamford Therapeutics Consortium
Stamford, Connecticut
Altus Research
Lake Worth, Florida
Miami Research Associates
Miami, Florida
Segal Institute for Clinical Research
North Miami, Florida
Meridien Research - St. Petersburg
St. Petersburg, Florida
Meridien Research - Tampa
Tampa, Florida
Comprehensive Clinical Trials, LLC
West Palm Beach, Florida
Fellows Research Alliance, Inc.
Savannah, Georgia
Rosemark WomenCare Specialists
Idaho Falls, Idaho
Bluegrass Clinical Research, Inc
Louisville, Kentucky
Johns Hopkins School of Medicine
Baltimore, Maryland
Beyer Research
Kalamazoo, Michigan
Lawrence OBGYN Clinical Research, LLC
Lawrenceville, New Jersey
The Center for Women's Health & Wellness, LLC
Plainsboro, New Jersey
Southwest Clinical Research
Albuquerque, New Mexico
NYU School of Medicine
New York, New York
Eastern Carolina Women's Center
New Bern, North Carolina
Wake Research Associates
Raleigh, North Carolina
Hawthorne Medical Research, Inc.
Winston-Salem, North Carolina
University of Cincinnati
Cincinnati, Ohio
Columbus Obstetricians-Gynecology, Inc./Radiant Research, Inc.
Columbus, Ohio
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Clinical Research Of Philadelphia
Philadelphia, Pennsylvania
Fellows Research Alliance, Inc.
Bluffton, South Carolina
Advanced Research Associates
Corpus Christi, Texas
Practice Research Organization
Dallas, Texas
TMC Life Research, Inc.
Houston, Texas
Physicians' Research Options
Draper, Utah
Physicians' Research Options
Pleasant Grove, Utah
Eastern Virginia Medical School
Norfolk, Virginia
Seattle Women's Health, Research, Gynecology
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.